Home
About
Overview
Sharing Data
ORCID
Help
History (19)
Newborn screening for hepatorenal tyrosinemia-I by tandem mass spectrometry using pooled samples: a four-year summary by the New England newborn screening program.
Atracurium
Competitive Bidding
Determinants of in vivo MR imaging of slow axonal transport.
Preferred therapies for neovascular age-related macular degeneration.
See All 19 Pages
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Preferred therapies for neovascular age-related macular degeneration.
Lally DR, Gerstenblith AT, Regillo CD. Preferred therapies for neovascular age-related macular degeneration. Curr Opin Ophthalmol. 2012 May; 23(3):182-8.
View in:
PubMed
subject areas
Angiogenesis Inhibitors
Antibodies, Monoclonal, Humanized
Bevacizumab
Humans
Ranibizumab
Receptors, Vascular Endothelial Growth Factor
Recombinant Fusion Proteins
Vascular Endothelial Growth Factor A
Wet Macular Degeneration
authors with profiles
David Lally MD